Ownership history in CITADEL ADVISORS LLC · 47 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in PROFOUND MED CORP (PROF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 10,073 | -36,237 | -78.2% | 0.00% | $50K | $4.89 |
| 2025 Q2 | REDUCED | 46,310 | -26,011 | -36.0% | 0.00% | $273K | $5.90 |
| 2025 Q1 | ADDED | 72,321 | +63,021 | +677.6% | 0.00% | $421K | $5.82 |
| 2025 Q1 | ADDED | 9,300 | +6,000 | +181.8% | 0.00% | $54K | $5.82 |
| 2025 Q1 | REDUCED | 3,300 | -42,791 | -92.8% | 0.00% | $19K | $5.82 |
| 2024 Q4 | ADDED | 46,091 | +44,691 | +3192.2% | 0.00% | $346K | $7.51 |
| 2024 Q4 | REDUCED | 1,400 | -2,500 | -64.1% | 0.00% | $11K | $7.51 |
| 2024 Q4 | REDUCED | 3,900 | -23,045 | -85.5% | 0.00% | $29K | $7.51 |
| 2024 Q3 | ADDED | 26,945 | +21,945 | +438.9% | 0.00% | $214K | $7.96 |
| 2024 Q3 | ADDED | 5,000 | +3,800 | +316.7% | 0.00% | $40K | $7.96 |
As of 2025 Q4 — sorted by position size